QA: Petros Pharmaceuticals Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001815903_2023_Petros_Pharmaceuticals_Inc.pdf

Logs

Graph

Absolute values for 0001815903, Petros Pharmaceuticals Inc.

  xvar xval
0 AssetsCurrent 14,667,905
1 IntangibleAssetsNetIncludingGoodwill 12,244,484
2 PropertyPlantAndEquipmentNet 39,177
3 remainder_Assets 5,469,648
4 LiabilitiesCurrent 7,067,976
5 LiabilitiesNoncurrent 262,678
6 remainder_Liabilities 8,388,093
7 CostOfGoodsAndServicesSold 2,289,418
8 SellingGeneralAndAdministrativeExpense 12,209,162
9 ResearchAndDevelopmentExpense 1,740,280
10 remainder_Expenses 10,264,961
11 remainder_Revenues 5,992,054
12 remainder_NetIncome 474,194
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 32,421,214
1 Liabilities 15,718,747
2 Expenses 26,503,821
3 Revenues 5,992,054
4 StockholdersEquity 16,702,467
5 NetIncome -20,037,573
6 ComprehensiveNetIncome -20,037,573
7 BaseVar 40,555,015
8 EconomicCapitalRatio 0.361

Edgar->Model Mapping

Feature Distribution

Change over Time